Telomerase study points researchers to targeted cancer drugs

Researchers at the University of Illinois at Urbana-Champaign and at the University of California, San Francisco, have been delving into the mechanisms by which mutations result in elevated expression of the protein called telomerase (TERT). Their study, published in Science, may lead to more personalized and better targeted cancer treatments with fewer side effects. They are working on inhibiting transcription factor activity that may dial down TERT expression and also spur "selective cancer cell death." Release

Suggested Articles

A team at Duke University has created the first functioning human muscle from skin cell-derived induced pluripotent stem cells.

Part of an international initiative, a pan-European observational study aims to improve clinical care of traumatic brain injury.

The past week's research news included developments in pediatric brain tumors, asthma and KRAS-mutant cancers.